C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 115 filers reported holding C4 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | -96.0% | 320 | -95.9% | 0.00% | – |
| Q1 2023 | $25 | -85.2% | 7,864 | -72.5% | 0.00% | – |
| Q4 2022 | $169 | -99.9% | 28,602 | +0.1% | 0.00% | – |
| Q3 2022 | $251,000 | +16.7% | 28,577 | +0.4% | 0.00% | – |
| Q2 2022 | $215,000 | -68.9% | 28,452 | -0.3% | 0.00% | -100.0% |
| Q1 2022 | $692,000 | -24.6% | 28,541 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $918,000 | -17.7% | 28,523 | +14.3% | 0.00% | 0.0% |
| Q3 2021 | $1,115,000 | -0.4% | 24,955 | -15.6% | 0.00% | 0.0% |
| Q2 2021 | $1,119,000 | +221.6% | 29,581 | +214.7% | 0.00% | – |
| Q1 2021 | $348,000 | +34.9% | 9,400 | +20.5% | 0.00% | – |
| Q4 2020 | $258,000 | – | 7,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |